Guia de pesquisa
Guias de pesquisa
Guias em linguagem simples sobre os compostos mais buscados: o que são, como são estudados, como conservar e verificar. Com fontes, somente para pesquisa de laboratório.
Retatrutide: what the research shows
Retatrutide is an investigational peptide that acts on three hormone receptors at once: GIP, GLP-1 and glucagon. What it is, what the published trials measured, what is still unknown and where it stands with regulators in October 2026.
Tirzepatide: what the research shows
Tirzepatide activates two gut-hormone receptors, GIP and GLP-1. How it was tested in the SURPASS and SURMOUNT trials, what the trials found about safety, its regulatory status and how research material differs from the approved medicine.
Semaglutide: what the research shows
Semaglutide is a long-acting analogue of the gut hormone GLP-1. What it is, the large trials behind it (SUSTAIN-6, STEP 1, SELECT), the safety findings, its regulatory status and why the salt form of a batch matters.
BPC-157: what the research shows
BPC-157 is a 15-amino-acid peptide studied mostly in rodent models of tendon, ligament, muscle and gut injury. What it is, what the evidence covers, what is missing in humans, and its status in sport.
TB-500 and thymosin beta-4: what the research shows
TB-500 is the name under which products related to thymosin beta-4, a natural repair peptide, are sold. What thymosin beta-4 does in cells and animal models, what TB-500 actually contained when it was analysed, the human data and its status in sport.
GHK-Cu: what the research shows
GHK-Cu is the copper complex of GHK, a three-amino-acid peptide found in human plasma, saliva and urine. What it is, what research on tissue remodelling, skin and gene expression covers, the limits of that evidence and how to check a batch.
Cagrilintide: what the research shows
Cagrilintide is an investigational long-acting analogue of amylin, a pancreatic hormone linked to satiety. How it was designed, what the trials alone and together with semaglutide measured, the safety findings and its regulatory status in October 2026.
MOTS-c: what the research shows
MOTS-c is a 16-amino-acid peptide encoded not in the cell nucleus but in mitochondrial DNA. What it is, what studies in cells and mice found about metabolism, muscle and ageing, what human data exist and its status in sport.
CBL-514: what the research shows
CBL-514 is an investigational small molecule studied for reducing localised fat. What it is, what the trials so far measured, the safety findings, where it stands with regulators in November 2026 and what its unpublished structure means for checking a batch.
Retatrutide vs tirzepatide vs semaglutide: what the research shows
Semaglutide, tirzepatide and retatrutide act on one, two and three hormone receptors. What the main trials reported, what the head-to-head trials found, the safety findings they share and where each one stands with regulators in November 2026.
NAD+: what the research shows
NAD+ is a coenzyme every cell uses to turn food into energy, and its levels fall with age. What it is, why it declines, what the human studies of raising it have measured, what is still unknown and how to check a batch.
Peptide purity: what “≥99% by HPLC” means
Research peptides are sold with a purity figure, usually measured by HPLC. What that number measures, where impurities come from, what it does not tell you, and what a complete certificate of analysis shows.
Bacteriostatic vs sterile water: the difference
Both are sterile while sealed. The difference is a preservative: bacteriostatic water contains benzyl alcohol, sterile water contains nothing else. What that changes, where benzyl alcohol is a problem, and what research on preservatives and peptides shows.
Mazdutide: what the research shows
Mazdutide, also known by its development codes IBI362 and LY3305677, is a peptide that activates both the GLP-1 and the glucagon receptor. What it is, what the trials in obesity and type 2 diabetes measured, the safety findings, where it stands with regulators in November 2026 and how to check a batch.
Survodutide: what the research shows
Survodutide, first studied under the code BI 456906, is an investigational peptide that activates both the glucagon and the GLP-1 receptor. What it is, what the trials in obesity and fatty liver disease measured, the safety findings, its regulatory status in November 2026 and how to check a batch.
Tesamorelin: what the research shows
Tesamorelin, also known by its development code TH9507, is a synthetic analogue of growth hormone-releasing hormone (GHRH). What it is, what the trials in people with HIV measured, the studies on liver fat and cognition, the safety findings, its regulatory and anti-doping status in November 2026 and how to check a batch.
Este guia resume pesquisas publicadas e informações regulatórias. Não é aconselhamento médico. Tudo o que vendemos é somente para pesquisa de laboratório in vitro, por adultos de 21 anos ou mais, e não para uso em pessoas ou animais.